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Several RNA tumor viruses cause leukemia after inoculation into mice. The Abelson 
leukemia virus (A-MuLV)  1 (1) causes a rapidly progressive lymphoid leukemia, originat- 
ing in the bone marrow or lymph nodes.  In addition,  A-MuLV quantitatively induces a 
leukemic transformation of hematopoietic cells in vitro (2, 3). The leukemic cells isolated 
in vivo or in vitro have the properties of neither mature T nor B cells (4), and are perhaps 
best  classified  as  null  cells.  The  Kirsten  sarcoma  virus  (KiSV)  causes  an  erythroid 
leukemia  (5). 
A-MuLV  and  KiSV  quantitatively  transform  NIH/3T3  cells  allowing  an  accurate 
determination  of virus titer.  Both viruses are defective and require a  competent helper 
virus to replicate. Viral transformed nonproducer NIH/3T3 cells free of helper virus have 
been  isolated  (5,  6).  Replicating  defective virus  can  be  rescued  from these  cells  aRer 
superinfection  with  a  competent helper  virus.  The super-infecting helper  virus deter- 
mines  the  pseudotype  (tropism  and  envelope  glycoprotein  antigens)  of the  defective 
virus. The replication of RNA tumor viruses is restricted by the Fv.1 locus of the mouse. 
Two codominant genetic alleles, Fv-1" and Fv-lb, determine susceptibility to infection by 
RNA tumor viruses.  Fv-l,,  mice are susceptible to infection by N- or NB-tropic viruses 
but are resistant to B-tropic viruses, while Fv-1  ~  mice are susceptible to B- or NB-tropic 
viruses but are resistant to N-tropic viruses (7,  8). 
I have rescued A-MuLV and KiSV from nonproducer cells with several helper 
viruses to study the effect of virus pseudotype on leukemogenesis.  I  found that 
the helper virus profoundly affects the incidence of erythroid leukemia  caused 
by KiSV and the lymphoid leukemia caused by A-MuLV. The helper virus also 
influences  the efficiency of A-MuLV-induced in vitro  transformation  of hema- 
topoietic cells.  The effect of the helper virus is independent of the Fv-1  locus of 
the mouse. 
Materials  and  Methods 
Viruses and Cells.  Clone 1 (9) of NB-tropic Moloney leukemia virus (M-MuLV) was obtained 
from Dr.  D.  Baltimore,  M.I.T.,  while NB-tropic Rauscher leukemia virus  (R-MuLV)  (10) was 
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obtained from Dr.  G. Todaro,  N.C.I.  The R-MuLV induced erythroid leukemia in vivo. N-tropic 
Friend polycythemia virus  (SFFV[F-MuLV])  (11)  was a  gift of Dr.  R.  Steeves,  Albert Einstein 
College of Medicine. The helper virus (F-MuLV) (12)  was freed from spleen focus-forming virus 
(SFFV)  by end  point dilution on NIH/3T3  cells.  A  tissue culture  passage  of N-tropic  Kirsten 
leukemia virus (Ki-MuLV) (13) which did not induce erythroid leukemia in vivo, was obtained 
from Dr.  J.  Stephenson,  N.C.I.  A  clonal isolate  (N35-MuLV)  of an N-tropic endogenous virus 
(WN1802N) (14) isolated from the spleen of a normal elderly BALB/c mouse was a  gift of Dr.  P. 
Jolicoeur, M.I.T. 
To obtain stocks of KiSV or A-MuLV as pseudotypes  with different helper viruses,  a  clonal 
isolate of KiSV-transformed NIH/3T3 cells (5),  or a  clonal isolate of A-MuLV-transformed NIH/ 
3T3 cells (ANN-l) (6) was infected with various N- or NB-tropic helper leukemia viruses. About 
106  KiSV-  or  A-MuLV-transformed  nonproducer  cells  were  infected  with  a  competent  helper 
virus in the presence ofpolybrene (4 ~g/ml) (Aldrich Chemical Co., Inc., Milwaukee, Wis.). Media 
was collected 1 wk later and passed through a  0.45-~m filter (Nalge Co., Nalgene Labware Div., 
Rochester, N.Y.).  The titer of the defective transforming virus, expressed as focus-forming units 
per  ml  (FFU/ml),  was  determined  on  NIH/3T3  cells  (5,  6).  The  cells  were  then  ultraviolet- 
irradiated and overlaid with XC cells to determine the titer of helper virus  (15),  expressed as 
plaque-forming units  per ml  (PFU/ml).  The  NIH/3T3  and  XC  cells were  grown  in  Dulbecco's 
modified Eagle's medium containing 10% calf serum (Colorado Serum Co. Denver, Colo.) at 37°C 
in a  humidified atmosphere containing 10% CO2. 
Mice.  C57/L (Fv-l"") and DBA/2De (Fv-l"") mice were purchased from The Jackson Labora° 
tory (Bar Harbor, Maine), while Swiss mice (CD-1) (Fv-l"") were purchased from Charles River 
Breeding  Laboratories  (Wilmington,  Mass.).  The  Swiss  mice  were  bred  randomly,  while  the 
inbred strains were maintained by brother-sister crosses. 
Induction  of Erythroid Leukemia.  Newborn  Swiss  mice  were  inoculated  intraperitoneally 
with 0.1 ml of filtered virus stock. 3-4 wk later, the animals were killed and autopsied.  Spleens 
were  sectioned  sagitally  and touch preparations  were  made  and treated  with  Wright-Giemsa 
stain. Animals with erythroblastic leukemia had grossly enlarged spleens which often ruptured, 
causing the death of the animal.  More than 30% of the cells in areas of erythroid leukemia were 
proerythroblasts or basophilic erythroblasts, and occasional trinucleate forms were seen (5).  The 
leukemia could be induced in hypertransfused mice. 
To assay for the replication of KiSV, spleens were shredded through a wire grid and a  10% (wt/ 
vol) cell suspension was made in medium. After removing the cells by low-speed centrifugation, 
the supernate was passed through a  0.45-~m membrane filter and assayed on NIH/3T3 cells (5). 
Induction of  Abelson Leukemia.  Newborn Swiss or DBA/2 mice were inoculated with 0.1 ml of 
filtered virus stock. The animals were examined daily for the presence of enlarged lymph nodes, 
cranial tumors, or paralysis. Mice with these findings were killed and autopeied. Animals scored 
as having Abelson leukemia had gross and histologic evidence of lymphoblastic infiltration of the 
marrow,  lymph nodes, and/or meninges with no involvement of the thymus (1). 
Abelson Virus-Induced  Hematopoietic  Cell Transformation.  The femoral bone marrow cells 
from 1 to 2-mo-old C57/L mice were collected in RPMI 1640 medium (Grand Island Biological Co., 
Grand Island, N.Y.) containing 20% heat (56°C)  inactivated fetal calf serum, and 5  ×  10 -5 M 2- 
mercapteethanol. The nucleated cells were diluted to 1 ×  106 cells/ml and polybrene was added to 
a concentration of 2 ~g/ml. The filtered virus stock (0.5 ml) was added to 1.5 ml of cell suspension 
and incubated at 37°C for 3 h. The cells were collected by low speed centrifugation (175 g) for 15 
rain  and resuspended in RPMI 1640 medium containing 20% heat inactivated  fetal  calf  serum, 5 
x 10  -5  M  2-mercaptoethanol, 0.3% (wt/vol)  agarose (Type  II;  Sigma Chemical Co.,  St.  Louis,  Mo.) 
at a concentration of  i × 106 nucleated cells/ml.  The cell  suspensions (1.5  ml) were added to 30- 
mm  plastic  dishes (Nunc Products, Vanguard International,  Red Bank, N.J.)  and incubated at 
37°C in a humidified atmosphere containing 8% CO2. The cultures  were fed  with 1 ml of  agarose 
medium at  5 and 10  days  postinfection.  Lymphoid colonies  containing more than 1,000  cells  were 
quantitated 12 days after  infection. 
Results 
KiSVoInduced Erythroid Leukemia.  KiSV was rescued from a transformed 
nonproducer of NIH/3T3  cells  with  NB-tropic  M-MuLV,  N-tropic  F-MuLV,  or 1046  VIRUS  PSEUDOTYPE  CONTROLS  LEUKEMOGENESIS 
N-tropic N35-MuLV and the titer of KiSV and helper virus were determined on 
NIH/3T3  cells.  Virus  stocks were inoculated into newborn Fv-1  nn  CD-1  Swiss 
mice,  a  strain  susceptible to KiSV-induced erythroid leukemia.  3-4 wk later, 
the animals were killed and their spleens were removed and examined to detect 
erythroid leukemia (5). 
Unlike  Friend  virus  (SFFV[F-MuLV])  (11),  KiSV  does  not  induce  clearly 
defined foci of erythroid leukemia that can be counted grossly (5). To quantitate 
the leukemogenic activity of the KiSV, the incidence of erythroid leukemia was 
correlated with the number of FFU inoculated. It was found that approximately 
102  FFU of KiSV(M-MuLV) or  103 FFU of KiSV(F-MuLV)  induced  erythroid 
leukemia in 50% of the mice (Fig. 1). As much as 105 FFU of KiSV(N35-MuLV), 
however, was required to induce leukemia in 50% of the mice,  demonstrating 
that the induction  of leukemia by the N35-MuLV pseudotype of KiSV was far 
less efficient. The helper viruses alone did not induce erythroid leukemia. The 
helper virus does, however, determine the efficiency of leukemogenesis induced 
by KiSV. This effect appears to be independent of the Fv-1 locus, since the Fv- 
1""  Swiss mice  used  in  these experiments  are  susceptible to  leukemogenesis 
induced by N-tropic KiSV(F-MuLV). 
Recovery of  KiSV from the Spleens of  Leukemic and Non-Leukemic Mice.  It 
is possible that the intraperitoneal  inoculum of KiSV did not reach the spleens 
of the non-leukemic mice. To learn if KiSV was present in the spleens of these 
mice, the spleens of both leukemic and non-leukemic mice were assayed for the 
presence of virus. Replicating KiSV could be recovered from the spleens of both 
leukemic and non-leukemic  animals inoculated with either KiSV(F-MuLV) or 
KiSV(N35-MuLV) (Table I), but not from mice infected with helper virus alone 
(5). Thus, the KiSV replicated in the spleen cells of the non-leukemic animals. 
Since  spleens  contain  a  heterogenous  group  of cells,  it  is  possible  that  the 
erythroid precursors of non-leukemic animals were not infected with KiSV. 
Although  KiSV replicated  in  the spleens of the non-leukemic  animals,  the 
titer of KiSV and helper virus (F-MuLV or N35-MuLV) was approximately 100- 
fold higher in the spleens of the leukemic animals.  This increased titer of virus 
in the leukemic mice probably reflects the replication of leukemia cells. 
A-MuLV-Induced Lymphoid Leukemia.  To learn if the helper viruses also 
influence A-MuLV-induced lymphoid leukemia,  A-MuLV was rescued from an 
A-MuLV-transformed nonproducer of NIH/3T3 cells (6) with several NB-tropic 
(M-MuLV  and  R-MuLV) and  N-tropic  (F-MuLV,  Ki-MuLV,  and  N35-MuLV) 
helper viruses.  The virus stocks were titered on NIH/3T3 cells and inoculated 
into newborn Swiss mice. Inoculation with 1 ×  103 FFU of A-MuLV(M-MuLV) 
induced Abelson leukemia  in 47% of the mice within  6 wk, while inoculation 
with  1  ×  102  FFU  did  not  cause  this  disease  (Table  II).  42%  of the  mice 
inoculated with 5 ×  103 FFU of A-MuLV(R-MuLV) and 17% of mice inoculated 
with 7 ×  103 of A-MuLV(F-MuLV) developed Abelson leukemia within 6 wk. In 
contrast,  mice inoculated with 1 ×  104 FFU of A-MuLV(N35-MuLV), or 5 ×  103 
FFU of A-MuLV(Ki-MuLV) did not develop Abelson leukemia. 
Inoculation of several of the helper viruses alone also induced leukemia, but 
these leukemias did not resemble Abelson disease. M-MuLV induced lymphoid 
thymic tumors after a  latent period of 3 mo, while F-MuLV induced lymphoid CHARLES  D.  SCHER  1047 
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FIG. i.  The induction of  erythroid leukemia by pseudotypes of  KiSV. Virus stocks were 
titered and cell-free  filtrates  were inoculated into newborn Swiss mice. 3-4 wk later the 
animals were killed,  touch preps of  the spleens were made and analyzed histologically  for 
evidence of  erythroid leukemia. 20-30 animals were used for each dilution of  virus stock. 
Legend:  ©  ..... O  KiSV(M-MuLV),  1 x  10  ~ FFU/ml;  1 x  10  e PFU/ml;  []  [] KiSV(F- 
MuLV)  1 x 10  s  FFU/ml, 2 x 10  e  PFU/ml; A  /x KiSV(N35-MuLV)  3 x 10  e FFU/ml, 1 × 
107 PFU/ml. 
TABLE  I 
Recovery of KiSV from the Spleens of Infected Mice* 
Virus inoculated  Erythroid$ leuke- 
mia 
Virus recovery 
FFU  PFU 
KiSV(F-MuLV)  Yes (3)  3 x 105-4 x 105  1 x 10  e 
No (2)  3 × 10s-7 × 10  s  1 × 104-1 × 105 
KiSV(N35-MuLV)  Yes (2)  4 × 104  1 x 105-6 x 10  s 
No (2)  5 × 102  1 x 10s-4 × 108 
* Newborn Swiss mice were inoculated with  KiSV(F-MuLV) 3  ×  108  FFU,  1  ×  l0  s  PFU,  or 
KiSV(N35-MuLV) 2  x  105 FFU, 5  ×  10  s PFU. 4 wk later the animals were killed, and touch 
preps of the spleens were made for histological examination. The spleens were then shredded 
through  a  wire  grid,  a  10%  (wt/vol) cell  suspension was  made,  passed through  a  0.45-pro 
membrane filter, and assayed on NIH/3T3 cells to determine the number of FFU of KiSV and 
PFU of helper virus per 0.5 ml of suspension. 
The number in parenthesis indicates the number of animals with or without erythroid leukemia 
whose spleens were removed and assayed. 
splenic  tumors detectable  6 wk or  more after  inoculation.  The R-MuLV used  in 
these experiments contained the SFFV component (16)  and many of  the mice 
developed erythroid  leukemia detectable  in the spleen  as early  as 3 wk after 
inoculation. N35-MuLV  and Ki-MuLV  did not induce leukemia during the 
period  of  observation.  The presence of  Abelson leukemia could  be differentiated 
from all of these other leukemias both grossly  and histologically.  Mice with 
Abelson leukemia developed lymphoid tumors within 3-6 wk of inoculation 
which involved  the bone marrow and/or peripheral  lymph nodes. Involvement 
of  the cranial  bone marrow and meninges was characteristic. 1048  VIRUS  PSEUDOTYPE  CONTROLS  LEUKEMOGENESIS 
TABLE  II 
The Effect of the Helper Virus on the Frequency  of A-MuLV-Induced Lymphoid 
Leukemia in Fv-l" Swiss Mice 
Leukemic mice$/  With leuke- 
Virus*  FFU inoculated 
total mice  mia 
% 
A-MuLV(M-MuLV)  1  x  104  17/25  68 
1  ×  103  8/17  47 
2  x  102  0/30  0 
A-MuLV(R-MuLV)  5  ×  105  8/19  42 
A-MuLV(F-MuLV)  7  ×  105  4/24  17 
A-MuLV(Ki-MuLV)  5  x  10 a  0/14  0 
A-MuLV(N35-MuLV)  1  x  104  0/12  0 
* Virus titers  were A-MuLV(M-MuLV)  4 x 104  FFU/ml, 2 x 105 PFU/ml; A-MuLV(R-MuLV)  5 x 
104  FFU/ml, 3 × 105  PFU/ml; A-MuLV(F-MuLV)  7 x 104  FFU/ml, 2 x 105  PFU/ml; A-MuLV(Ki- 
MuLV)  5 x 104 FFU/ml, 2 x 104 PFU/ml; A-MuLV(N35-MuLV)  1 x 105 FFU/ml, 5 × 105 PFU/ 
ml. 
Mice with Abelson leukemia/total number of  mice. 
DBA/2 mice, an Fv-1  nn inbred strain, are also susceptible to Abelson leuke- 
mia.  Inoculation of 1  x  103  FFU of A-MuLV(M-MuLV) into newborn DBA/2 
mice induced Abelson leukemia in 90% of the animals, and 7  x  108 FFU of A- 
MuLV(F-MuLV) caused Abelson leukemia in 51%. A-MuLV(Ki-MuLV) (5  x 
103  FFU)  or  A-MuLV(N35-MuLV)  (1  x  104  FFU)  did  not  induce  Abelson 
leukemia in these mice  (Table  III).  The experiments with DBA/2  and Swiss 
mice demonstrate that the helper virus determines the incidence of A-MuLV- 
induced lymphoid leukemia. 
Transformation  of Bone Marrow Cells  by A-MuLV.  The pseudotype of A- 
MuLV  may  directly  affect  its  ability  to  cause  a  leukemic  change  in  the 
hematopoietic cells.  To test this hypothesis bone  marrow cells were infected 
with various pseudotypes of A-MuLV. Marrow was taken from C57/L mice, a 
Fv-1  nn  inbred strain susceptible to  infection by N-  or  NB-tropic  viruses; the 
marrow cells of this strain can readily be transformed by A-MuLV(M-MuLV) 
(3). Cells were infected with pseudotypes of A-MuLV and plated in an agarose 
gel  containing 5  x  10 -5  M  2-mercaptoethanol.  Large transformed lymphoid 
colonies,  consisting of 1,000 or  more  cells,  were  identified 12-14  days later. 
These colonies were not noted in mock-infected cultures, or in cultures infected 
with the helper viruses alone. 
Infection of marrow cells with 1.5  x  l0  s FFU of A-MuLV(M-MuLV) trans- 
formed 9.7 lymphoid colonies per plate, while infection with 1.5  x  104 FFU of A- 
MuLV(M-MuLV) transformed 1.5  colonies per  plate.  At either  multiplicity, 
approximately 5-10 transformed lymphoid colonies were found per 105 FFU of 
A-MuLV(M-MuLV) added  (Table  IV).  Infection with A-MuLV(R-MuLV) al- 
lowed the recognition of 6.5 transformed colonies per 10  ~ FFU, while infection 
with A-MuLV(F-MuLV) caused the growth of four transformed colonies per l0  s CHARLES  D. SCHER 
TABLE  HI 
The Effect of the Helper Virus on the Frequency of A-MuLV- 
Induced Lymphoid Leukemia in Fv-l"" DBA/2 Mice 
Leukemic 
FFU inocu-  With leu-  Virus*  mice/total  lated  kemia 
mice 
A-MuLV(M-MuLV) 
% 
1  ×  104  6/6  100 
1  ×  103  9/10  90 
1 ×  10  ~  0/20  0 
A-MuLV(F°MuLV)  7  x  103  21/41  51 
A-MuLV(Ki-MuLV)  5  x  103  0/14  0 
A-MuLV(N35-MuLV)  1  ×  104  0/10  0 
* Virus titers were A-MuLV(M-MuLV) 1  x  10  ~ FFU/ml,  1  ×  106 PFU/ 
ml; A-MuLV  (F-MuLV) 7  ×  104 FFU/ml,  2  ×  105 PFU/ml; A-MuLV 
(Ki-MuLV) 5 ×  104 FFU/ml, 2 x  10' PFU/ml; A-MuLV (N35-MuLV) 1 
×  10  s FFU/ml, 5  ×  106 PFU/ml. 
TABLE  IV 
The Effect of the Helper Virus on the Frequency of A-MuLV-Induced Bone 
Marrow Cell Transformation  in Fv-l"" C57/L Mice 
1049 
Trans- 
FFU inocu-  Transformed  Transformed  formed col- 
Virus*  lated$ per  colonies§/total 
plate (×  105)  plates  colonies/plate  onies/10  s 
FFU 
A-MuLV(M-MuLV)  1.5  97/10  9.7  6.5 
0.15  15/10  1.5  l0 
A-MuLV(R-MuLV)  1.0  65/10  6.5  6.5 
A-MuLV(F-MuLV)  0.35  14/10  1.4  4.0 
A-MuLV(Ki-MuLV)  0.30  0/13  0  0 
A-MuLV(N35-MuLV)  0.50  1/21  0.04  0.1 
None  0  0/20  0  0 
* Virus  titers  were  A-MuLV(M-MuLV)  3  ×  105  FFU/ml,  2  x  10  e PFU/ml;  A-MuLV(R- 
MuLV), 2  ×  l0  s FFU/ml, 6  ×  105 PFU/ml; A-MuLV(F-MuLV) 7  x  104 FFU/ml, 2  x  10  ~ 
PFU/ml; A-MuLV(Ki-MuLV) 4  ×  104 FFU/ml,  2  ×  104 PFU/ml; A-MuLV(N35-MuLV)  1 
×  105 FFU/ml, 5  ×  10  ~ PFU/ml. 
$ Bone marrow cells (1.5 ×  10  ~) were inoculated with the FFU of virus shown, and after the 
adsorption period, were placed in a  soft agarose gel in a  single plate. 
§ Transformed  colonies  of  lymphoid  cells  were  enumerated  12  days  after  the  virus 
adsorption period. 
FFU.  A-MuLV(N35-MuLV)  and  A-MuLV(Ki-MuLV),  however,  transformed 
these  bone  marrow  cells  poorly.  Approximately  0.1  transformed  lymphoid 
colonies  were  found  per  105  FFU  of A-MuLV(N35-MuLV),  while  no  colonies 
were  detected  after  infection  with  A-MuLV(Ki-MuLV).  Thus,  the  helper  virus 
profoundly  influences  the  ability  of A-MuLV  to  induce  a  leukemic  change  in 
hematopoietic  cells in vitro. 
Complementation  of A-MuLV-Induced  Transformation  by  M-MuLV.  To 
learn  if MoMuLV  complements  A-MuLV  to allow  the  transformation  of hema- 1050  VIRUS  PSEUDOTYPE  CONTROLS  LEUKEMOGENESIS 
TABLE V 
The Effect of Added M-MuLV on the Frequency of Bone Marrow Cell Transformation 
by A-MuLV(N35-MuLV) 
Virus* 
FFU Inoc-  Trans- 
Addition of  Transformed  Trans- 
ulated per  M-MuLV$  colonies/total  formed col-  formed col- 
plate (×  (moi 3)  plates  onies/plate  °nies/105 
105  )  FFU 
A-MuLV  (M-MuLV)  0.5  No  106/10  10.6  21.2 
Yes  30/10  3.0  6.0 
A-MuLV(N35-MuLV)  0.5  No  1/10  0.1  0.2 
Yes  0/10  0  0 
None  0  No  0/20  0  0 
Yes  0/20  0  0 
* Virus titers  determined on NIH/3T3 cells:  A-MuLV(M-MuLV)  1 x 10  s  FFU/ml, 2 x 10  ~  PFU/ml; 
A-MuLV(N35-MuLV)  1 x  10  s FFU/ml,  i x  105 PFU/ml; M-MuLV  i x  107 PFU/ml. 
topoietic cells,  bone  marrow cells were infected with poorly transforming A- 
MuLV(N35-MuLV) in the presence of excess M-MuLV (multiplicity of infection 
[moi 3]). This added M-MuLV did not increase the frequency of transformation 
induced by A-MuLV(N35-MuLV)  (Table  V).  Similarly, M-MuLV  did  not in- 
crease the frequency of transformation induced by A-MuLV(M-MuLV). Thus, 
the  pseudotype  of A-MuLV,  rather  than  the  presence  of a  complementing 
effective helper virus, determines the lymphoid transformation frequency. 
Isolation of an A-MuLV-Transformed Lymphoid Nonproducer.  Four clones 
of lymphoid cells from C57/L mice were isolated from cultures infected with A- 
MuLV(M-MuLV) grown to mass culture and studied for the replication of A- 
MuLV  and  M-MuLV.  Three of these clones released infectious A-MuLV(M- 
MuLV) while one (clone 3) released neither infectious A-MuLV nor M-MuLV. 
Media in which clone 3 was grown contained no detectable reverse transcriptase 
demonstrating that it was not producing virus particles. After infection with M- 
MuLV, clone 3 released infectious A-MuLV which transformed NIH/3T3 cells. 
This  experiment demonstrates that the  A-MuLV  component of A-MuLV(M- 
MuLV) transformed the bone marrow cells. 
Discussion 
Several  defective viruses  induce  leukemia after inoculation into  mice.  A- 
MuLV causes a  null cell lymphoid leukemia (1,  4),  while SFFV (11,  16)  and 
KiSV (5) induce an erythroid leukemia. The helper viruses do not produce these 
types of leukemia. The present study shows that the helper virus determines 
the leukemogenic activity of A-MuLV for lymphoid cells and KiSV for erythroid 
cells. 
The murine genetic locus, Fv-1, restricts the replication of competent helper 
viruses.  Restriction is dominant and appears to act after virus absorption and 
penetration (17, 18). The pseudotype of a defective agent, including its N- or B- 
tropism, is determined by the helper virus (19). The Fv-1  locus can restrict both 
the sarcoma virus-induced transformation of fibroblasts in vitro (19), and SFFV- CHARLES  D.  SCHER  1051 
induced erythroid leukemia in vivo (8). In the present study Fv-1  nn hosts were 
infected with N- or NB-tropic pseudotypes of defective viruses. The viruses were 
grown and titered on FV-1 nn NIH/3T3 cells. However, these virus stocks varied 
widely in their ability to induce leukemia.  Clearly the Fv-1  ~ phenotype is not 
responsible for the observed restriction of leukemogenic activity. 
There  are  two classes  of murine  ecotropic  helper  viruses.  The  endogenous 
viruses,  typified by N35-MuLV,  are  integrated  into  the host's germ line,  and 
are  inherited  in  a  vertical  fashion.  These  viruses  may begin  to  replicate  in 
elderly  mice and  can often be induced to replicate  in  cells in  vitro,  after the 
addition of halogenated pyrimidines (20). Inoculation of endogenous viruses into 
susceptible  mice  may  result  in  the  formation  of tumors,  but  these  tumors 
usually  apear  at  low frequency  after  a  prolonged  latent  period that  is  often 
greater than  1 yr (21).  The exogenous viruses, typified by F-MuLV, M-MuLV, 
and R-MuLV (FMR group), are usually not inherited vertically (22). Inoculation 
of helper FMR viruses into mice results in a high frequency of lymphoid tumors 
with a shorter latent period (11/2-6 mo). The present study shows that an FMR- 
pseudotype of either  A-MuLV or KiSV  induces  leukemia far more efficiently 
than an N35-MuLV endogenous virus pseudotype of these two defective trans- 
forming  viruses.  In  addition,  a  Ki-MuLV  pseudotype  of A-MuLV  does  not 
induce Abelson leukemia.  Ki-MuLV shares common envelope and p12 antigens 
with  the  endogenous  viruses  (13).  Thus,  mice  appear  to  be  able  to  restrict 
leukemia  induced by endogenous viruses alone,  and leukemia induced  by an 
endogenous virus pseudotype of a  defective transforming virus. 
Virus spread may contribute to the induction of leukemia in vivo by either A- 
MuLV  or  KiSV.  Certainly,  the  titer  of  KiSV  present  in  the  spleens  of 
nonleukemic animals is lower than the titer in leukemic animals  (Table I). In 
addition,  an  endogenous  virus pseudotype of A-MuLV,  that  does not  induce 
leukemia in vivo, cannot be recovered from the hematopoietic tissues of mice 
(23). 
To study a single-step leukemia transformation event, I infected bone marrow 
cells with pseudotypes of A-MuLV and  plated the cells in  a  soft agarose gel. 
Rosenberg  and  Baltimore  (3)  have  demonstrated  that  the  number  of trans- 
formed lymphoid cells recognized in this gel culture system is directly propor- 
tional  to  the  virus  inoculum  (one-hit  kinetics).  Thus,  transformation  is  the 
result of a  single-step event rather than being caused by virus spread. 
The  A-MuLV  genome  appears  to  be  responsible  for  inducing  leukemic 
transformation,  because nonproducer  cells have  been isolated.  These  nonpro- 
ducer lymphoid cells are isolated at a low frequency (1/4) because of the presence 
of excess  helper  virus  in  the  inoculum.  Murine  sarcoma  virus-transformed 
nonproducer  BALB/c-3T3 cells have been  isolated  at a  comparable  frequency 
(24). 
Although A-MuLV appears to contain the genetic information that controls 
lymphoid cell transformation,  the present  study shows that  the  helper  virus 
also has an important role. FMR helpers allow a high frequency of transforma- 
tion  while  the  N35-MuLV  endogenous  virus  or  Ki°MuLV  do  not.  Mixing 
experiments  demonstrate  that  the  addition  of an  effective helper  such  as  M- 
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lymphoid transformation. Since complementation does not occur,  the pseudo- 
type of A-MuLV, rather than the presence of an exogenous effective helper, 
controls the transformation of hematopoietic cells. 
The pseudotype of A-MuLV affects its ability to transform hematopoietic cells 
in vitro. It is likely that the pseudotype of A-MuLV and KiSV, rather than the 
presence of an effective complementing helper also controls leukemogenesis in 
vivo. This control of leukemogenesis by the helper virus may be a general one. 
N35-MuLV and Ki-MuLV pseudotypes of A-MuLV and KiSV readily trans- 
form NIH/3T3 fibroblast-like cells. However, the virus-induced leukemic change 
in hematopoietic cells is restricted both in vivo and in vitro. The mechanism of 
restriction remains unclear. One possibility is that the hematopoietic cells block 
an early event in the infectious cycle. 
Summary 
Nonproducer cells transformed by Kirsten sarcoma virus (KiSV) or Abelson 
murine leukemia virus  (A-MuLV) were infected with N- or NB-tropic helper 
viruses to rescue the defective transforming virus. The titer of the transforming 
viruses was determined on NIH/3T3 fibroblast-like cells and cell-free filtrates of 
virus stock were inoculated into newborn Fv-1  nn  mice.  Friend,  Moloney, and 
Rauscher group of MuLV (FMR) pseudotypes of KiSV induced an erythroid 
leukemia efficiently, while an endogenous helper  (N35-MuLV)  pseudotype of 
KiSV  did not.  FMR pseudotypes of A-MuLV induced the  Abelson lymphoid 
leukemia, while the N35-MuLV or a Kirsten leukemia virus (Ki-MuLV) pseudo- 
type did not. 
Pseudotypes of A-MuLV were used to infect bone marrow cells of Fv-1  nn mice 
in vitro. The FMR pseudotypes transformed bone marrow cells at 40-100-fold 
higher frequency than the N35-MuLV or Ki-MuLV pseudotypes. Mixing experi- 
ments demonstrated that the addition of an effective helper, such as M-MuLV, 
did not enhance lymphoid transformation by ineffective A-MuLV(N35-MuLV). 
The A-MuLV genome is responsible for hematopoietic cell transformation be- 
cause a nonproducer clone of lymphoid cells, free of helper virus, was isolated. 
The data indicates that the pseudotype of A-MuLV determines its ability to 
transform hematopoietic cells. 
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